Julia Barasch
5 Papers
Julia Barasch is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE
Anca Askanase,Cynthia Aranow,Mimi Y. Kim,Diane L. Kamen,Cristina Arriens,Leila Khalili,Wei Tang,Julia Barasch,Maria Dall'Era,Meggan Mackay +9 more
TL;DR: In this paper , the authors evaluated the level of agreement between virtual SLE outcome measures and face-to-face (F2F) encounter using the Bland-Altman method.
3
The Evolving Role of Telemedicine in the Care of Patients with Connective Tissue Diseases.
Julia Barasch,Wei Tang,Leila Khalili,Anca Askanase +3 more
TL;DR: This study examines the evolving role of telemedicine in managing patients with connective tissue diseases, highlighting its benefits, challenges, and future directions in improving patient outcomes and healthcare access.
1
617 Evaluation of SLE outcome measures in telemedicine: interim analysis results
Anca Askanase,Cynthia Aranow,Mimi Y. Kim,Diane L. Kamen,Cristina Arriens,Wei Tang,Leila Khalili,Julia Barasch,Maria Dall'Era,Meggan Mackay +9 more
- 01 Dec 2022
TL;DR: In this article , the authors evaluated the level of agreement between physician-assessed virtual and face-to-face SLE outcome measures, showing a high level of correlation between TM and F2F measures.
609 Demographic and clinical factors that contribute to clinical study enrollment
Sean Inzerillo,J. Weiner,Wei Tang,Leila Khalili,Julia Barasch,Peter M. Izmirly,Shira Kaplan,Laura Geraldino-Pardilla,Yevgenya Gartshteyn,Nancyanne Schmidt,Anca Askanase +10 more
- 01 Dec 2022
TL;DR: In this article , the authors evaluated factors associated with challenges to clinical trial enrollment in the Columbia University Lupus Cohort (CU) and found that patients with systemic lupus erythematosus (SLE), especially those of African-American and Hispanic descent have been reluctant to participate in clinical trials.
The Impact of Telemedicine on Rheumatology Care
Wei Tang,Sean Inzerillo,J. Weiner,Leila Khalili,Julia Barasch,Yevgeniya Gartshteyn,Maria Dall'Era,Cynthia Aranow,Meggan Mackay,Anca Askanase +9 more
TL;DR: The stable number of office visits, admissions, and the similar quality of life to pre-pandemic level suggest effective management of rheumatic diseases using telemedicine/in-person hybrid care.